Exencial Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.3M | Buy |
81,932
+1,076
| +1% | +$28.6K | 0.07% | 208 |
|
|
2025
Q4 | $2.01M | Buy |
80,856
+1,110
| +1% | +$28K | 0.06% | 223 |
|
|
2025
Q3 | $2.03M | Buy |
79,746
+9,198
| +13% | +$227K | 0.07% | 217 |
|
|
2025
Q2 | $1.71M | Sell |
70,548
-6,168
| -8% | -$144K | 0.06% | 232 |
|
|
2025
Q1 | $1.94M | Buy |
76,716
+1,254
| +2% | +$32.8K | 0.07% | 216 |
|
|
2024
Q4 | $2M | Sell |
75,462
-1,614
| -2% | -$43.8K | 0.07% | 207 |
|
|
2024
Q3 | $2.23M | Sell |
77,076
-5,233
| -6% | -$153K | 0.08% | 204 |
|
|
2024
Q2 | $2.3M | Buy |
82,309
+1,761
| +2% | +$48.5K | 0.09% | 197 |
|
|
2024
Q1 | $2.24M | Sell |
80,548
-15,408
| -16% | -$428K | 0.08% | 200 |
|
|
2023
Q4 | $2.76M | Sell |
95,956
-8,694
| -8% | -$263K | 0.11% | 166 |
|
|
2023
Q3 | $3.47M | Sell |
104,650
-8,898
| -8% | -$315K | 0.17% | 138 |
|
|
2023
Q2 | $4.16M | Buy |
113,548
+823
| +0.7% | +$32K | 0.19% | 126 |
|
|
2023
Q1 | $4.6M | Sell |
112,725
-5,180
| -4% | -$224K | 0.24% | 112 |
|
|
2022
Q4 | $6.04M | Buy |
117,905
+10,158
| +9% | +$487K | 0.32% | 92 |
|
|
2022
Q3 | $4.71M | Sell |
107,747
-12,267
| -10% | -$596K | 0.29% | 104 |
|
|
2022
Q2 | $6.29M | Buy |
120,014
+304
| +0.3% | +$15.5K | 0.36% | 90 |
|
|
2022
Q1 | $6.2M | Buy |
119,710
+4,255
| +4% | +$221K | 0.31% | 109 |
|
|
2021
Q4 | $6.82M | Sell |
115,455
-34,548
| -23% | -$1.71M | 0.33% | 107 |
|
|
2021
Q3 | $6.45M | Buy |
150,003
+32,957
| +28% | +$1.46M | 0.28% | 94 |
|
|
2021
Q2 | $4.58M | Buy |
117,046
+9,383
| +9% | +$365K | 0.25% | 118 |
|
|
2021
Q1 | $3.9M | Sell |
107,663
-8,858
| -8% | -$315K | 0.23% | 134 |
|
|
2020
Q4 | $4.29M | Sell |
116,521
-329,404
| -74% | -$12.1M | 0.29% | 108 |
|
|
2020
Q3 | $15.5M | Buy |
445,925
+200,244
| +82% | +$7.02M | 0.82% | 34 |
|
|
2020
Q2 | $7.62M | Buy |
245,681
+192,839
| +365% | +$6.55M | 0.66% | 39 |
|
|
2020
Q1 | $1.64M | Buy |
52,842
+4,986
| +10% | +$170K | 0.29% | 86 |
|
|
2019
Q4 | $1.78M | Sell |
47,856
-1,258
| -3% | -$44.8K | 0.31% | 94 |
|
|
2019
Q3 | $1.67M | Buy |
49,114
+4,853
| +11% | +$176K | 0.36% | 83 |
|
|
2019
Q2 | $1.82M | Hold |
44,261
| – | – | 0.42% | 71 |
|
|
2019
Q1 | $1.78M | Buy |
44,261
+10,258
| +30% | +$411K | 0.42% | 73 |
|
|
2018
Q4 | $1.41M | Sell |
34,003
-4,218
| -11% | -$175K | 0.38% | 75 |
|
|
2018
Q3 | $1.6M | Sell |
38,221
-1,829
| -5% | -$70.4K | 0.37% | 71 |
|
|
2018
Q2 | $1.38M | Sell |
40,050
-399
| -1% | -$13.6K | 0.38% | 71 |
|
|
2018
Q1 | $1.36M | Sell |
40,449
-2,446
| -6% | -$84.1K | 0.41% | 68 |
|
|
2017
Q4 | $1.47M | Buy |
42,895
+1,171
| +3% | +$39.9K | 0.44% | 65 |
|
|
2017
Q3 | $1.41M | Sell |
41,724
-201
| -0.5% | -$6.46K | 0.47% | 66 |
|
|
2017
Q2 | $1.34M | Sell |
41,925
-1,358
| -3% | -$42.8K | 0.55% | 53 |
|
|
2017
Q1 | $1.38M | Sell |
43,283
-1,556
| -3% | -$49.1K | 0.6% | 52 |
|
|
2016
Q4 | $1.38M | Buy |
44,839
+4,974
| +12% | +$152K | 0.59% | 54 |
|
|
2016
Q3 | $1.2M | Buy |
39,865
+704
| +2% | +$23.5K | 0.53% | 56 |
|
|
2016
Q2 | $1.31M | Buy |
39,161
+2,957
| +8% | +$94.4K | 0.59% | 56 |
|
|
2016
Q1 | $1.02M | Buy |
36,204
+420
| +1% | +$12K | 0.48% | 64 |
|
|
2015
Q4 | $1.05M | Buy |
35,784
+2,010
| +6% | +$63.2K | 0.52% | 58 |
|
|
2015
Q3 | $1.01M | Sell |
33,774
-1,196
| -3% | -$38.3K | 0.49% | 64 |
|
|
2015
Q2 | $1.15M | Sell |
34,970
-1,804
| -5% | -$58.8K | 0.73% | 44 |
|
|
2015
Q1 | $1.23M | Sell |
36,774
-305
| -0.8% | -$9.7K | 0.52% | 62 |
|
|
2014
Q4 | $1.15M | Buy |
37,079
+1,072
| +3% | +$30.7K | 0.51% | 60 |
|
|
2014
Q3 | $1.01M | Buy |
36,007
+391
| +1% | +$11K | 0.45% | 66 |
|
|
2014
Q2 | $1.01M | Sell |
35,616
-1,584
| -4% | -$45.2K | 0.43% | 68 |
|
|
2014
Q1 | $1.06M | Buy |
37,200
+356
| +1% | +$10.6K | 0.44% | 72 |
|
|
2013
Q4 | $1.09M | Buy |
36,844
+14
| +0% | +$407 | 0.5% | 65 |
|
|
2013
Q3 | $1.09M | Sell |
36,830
-2,076
| -5% | -$56.5K | 0.51% | 63 |
|
|
2013
Q2 | $1.08M | Buy |
+38,906
| New | +$1.07M | 0.54% | 61 |
|
Other funds holding PFE
Exencial Wealth Advisors's PFE Position: Q1 2026 in Review
Exencial Wealth Advisors increased its Pfizer (PFE) stake by 1.3% in Q1 2026, buying an estimated $28.6K and bringing the position to 81,932 shares worth $2.3M. The position accounts for 0.07% of the portfolio, ranked #208.
Exencial Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.5M in Q3 2020. 2,953 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Exencial Wealth Advisors held 81,932 shares of Pfizer worth $2.3M as of Q1 2026.
- Exencial Wealth Advisors bought 1,076 Pfizer shares in Q1 2026, an estimated $28.6K.
- Pfizer made up 0.07% of Exencial Wealth Advisors's portfolio in Q1 2026, its #208 holding.
- Exencial Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Exencial Wealth Advisors's Pfizer position peaked at $15.5M in Q3 2020.
- 2,953 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.